FDA Investigators Offer 8 Inspectional Insights
This article was originally published in The Silver Sheet
Exclusive Online-Only Content >>> FDA investigators Ben Dastoli and Laureen Geniusz offer expert tips on inspections to medical device manufacturers. Part 1 of 3.
You may also be interested in...
A US National Academies meeting on digital health technology showcased the communication gap between regulators and tech developers when it comes to important concepts like “digital biomarkers.”
The Onyx One Clear study, evaluating the Resolute Onyx drug-eluting stent in high bleeding risk patients, met its primary endpoint at the one-year follow up.
Dozens of life science companies are working to find effective treatments for COVID-19. In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into some of the efforts that are under way on this front.